SCHEMBL24628795

SCHEMBL24628795

CN(c1ccccc1NS(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C(=O)OC2CCCCC2)C1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.42
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
HPGD P15428 1/20 0.39
NPY2R P49146 1/20 0.38
MAPT P10636 1/20 0.38
MOGAT2 Q3SYC2 1/20 0.38
POLB P06746 1/20 0.37
GAA P10253 2/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CCR5 P51681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29772864 1.00 MCOLN2 (0.42) MCOLN2KMT2AKDM4EALDH1A1LMNA
SCHEMBL29772899 0.86 LIMK2 (0.48) NPY2R
SCHEMBL24628229 0.86 LIMK2 (0.48) NPY2R
SCHEMBL24628372 0.86 NPY2R (0.52) MCOLN2KMT2AKDM4EALDH1A1LMNA
SCHEMBL29772863 0.86 NPY2R (0.52) MCOLN2KMT2AKDM4EALDH1A1LMNA
SCHEMBL30936639 0.80 LIMK2 (0.51) NPY2R
SCHEMBL31720818 0.80 LMNA (0.51) MCOLN2KMT2AKDM4EALDH1A1LMNA
SCHEMBL24628788 0.79 MCOLN2 (0.46) MCOLN2KMT2AALDH1A1GAAL3MBTL1
SCHEMBL31720602 0.79 LMNA (0.49) MCOLN2KMT2AKDM4EALDH1A1LMNA
SCHEMBL31720603 0.78 MCOLN2 (0.49) MCOLN2KMT2AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022150461-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2022-07-14 WO disclosed